Breaking Down Instead of Silencing: A Step Forward in a New Class of Drugs
Biologists at Stanford University have developed the LYTAC, a new class of drug that might be the future of therapeutics due to its ability to breakdown previously un-accessible proteins on cell walls and its adaptability.